Diabetic Foot Ulcers Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2024-2032)

Diabetic Foot Ulcers Market Outlook

• The increasing number of diabetes cases, in addition to advancements in wound care technologies such as skin substitutes and antimicrobial dressings, is fueling the growth of the market. These advancements are expected to enhance the market value in the forecast period.
• One of the major market trends include increasing partnerships between affluent companies. In March 2023, Mylab collaborated with DnaNudge to create a kit for detecting diabetic foot ulcers. This partnership assisted in identifying and customizing treatment for diabetic foot infections early on, aiming to improve treatment results. 
• With its advanced healthcare infrastructure and high healthcare spending, the United States is at the forefront of the market.

Diabetic Foot Ulcers Market Overview

Diabetic foot ulcers are a medical condition characterized by wounds or sores on the feet and slow healing or non-healing because of poor blood or vascular circulation, or peripheral neuropathy in diabetic patients. These ulcers can prove disastrous if not well managed as they can cause infections, gangrene, and ultimately amputation. Since diabetes incidence is increasing worldwide, the management and handling of diabetic foot ulcers are emerging as an essential area of concern amongst researchers and major market players, leading to the advent of several innovative treatment alternatives.

Diabetic Foot Ulcers Market Growth Drivers

Rising Prevalence of Diabetes Boosts the Market Growth

The rising occurrence of diabetes is a key factor driving the market growth. In 2023, the International Diabetes Federation estimated that by 2045, 1 in 10 adults will be diagnosed with the disease for an overall of 783 million people across the globe. Over 90% of them will develop type 2 diabetes because of socio-economic, demographic, environmental, and genetics. Population growth, particularly in urban areas, rising elderly population, low physical activity, and higher prevalence of overweight and obesity are major drivers of the market growth.

Advancements in Wound Care to Meet Rising Diabetic Foot Ulcers Market Demand

It has been observed that the market for diabetic foot ulcers has expanded because of the progress in the technology of wound care such as advanced dressings and skin substitutes. Such technologies enhance the rate of healing, protect the patient from infections, and facilitate quicker recovery. Through the simulation of natural skin, the skin substitutes act as a barrier and promote tissue formation thereby improving the patients’ results and fostering market growth.

Diabetic Foot Ulcers Market Trends

Emphasis on Early Diagnosis via Partnerships Between Market Players

In March 2023, Pune-based, Mylab Discovery Solutions, collaborated with the DnaNudge, a UK-based company, to launch a diabetic foot ulcer detection kit. This ground-breaking kit detects bacteria in infections and offers molecular antimicrobial resistance data in an hour. It allows doctors to define which antibiotic should be used for each individual and minimize the chances of antimicrobial resistance. This partnership is expected to help a large number of diabetic patients in India at risk of having their limbs amputated by diagnosing and managing them effectively for diabetic foot infections.

Telemedicine and Remote Monitoring to Enhance Diabetic Foot Ulcers Market Value

Telemedicine and wearable technology have revolutionized diabetic foot ulcer care by enabling remote monitoring, early detection of complications, and real-time treatment adjustments, enhancing patient convenience, reducing hospital visits, and improving treatment outcomes.

Adoption of Novel Therapeutics for Effective Management and Treatment

Alternative therapeutic methods, including stem cell and tissue engineering, are being increasingly applied in the treatment of diabetic foot ulcers. Such strategies enhance quicker healing of the wound as they trigger the formation of new tissue besides minimizing the possibility of an infection. They may represent an efficient treatment approach compared to conventional methods, especially in the case of chronic or nonhealing ulcers.

Preference for Personalized Medicine to Impact the Diabetic Foot Ulcers Market Size Positively

The adoption of personalised approaches targeting genetics, and medical records is one of the major market trends. This personalization of the treatment is aimed at enhancing the results thereby reducing the chances of negative side effects. It guarantees the client optimal treatment that is specific to their illness or disorder.

Diabetic Foot Ulcers Market Segmentation

Market Breakup by Ulcer Type

• Neuropathic Ulcer
• Ischemic Ulcer
• Neuro-ischemic Ulcer

Market Breakup by Product

• Wound Care Dressings
  • Alginate Dressings
  • Hydrofiber Dressings
  • Surgical Dressings
  • Hydrogel Dressings
  • Foam Dressings
  • Film Dressings
  • Hydrocolloid Dressings
• Biologics
  • Growth Factors
  • Skin Grafts
• Therapy Devices
  • Negative Wound Pressure Therapy
  • Ultrasound Therapy
• Antibiotic Medications
• Others

Market Breakup by End User

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Homecare Settings

Market Breakup by Region

• United States
• EU-4 and the United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
• Japan
• India

Diabetic Foot Ulcers Market Share

Market Segmentation Based on End User Set to Witness Substantial Growth

The market is divided into hospitals, clinics, ambulatory surgical centers, and home care settings based on the end user. Among these, hospitals are anticipated to have the largest market share as they provide vital mechanisms for well-established protocols and adequate human resources to handle complex operational conditions.

Diabetic Foot Ulcers Market by Region

Based on the region, the market report includes an insight into the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. Among these, the United States is expected to dominate the market due to the large healthcare spending and players in the pharmaceutical industry. Strong research activities and governmental measures to contribute to cancer research are some of the factors helping the market development in the region. 

In the forecast period, India is expected to hold a significant market share, owing to an increasing health consciousness and betterment of medical facilities. This aspect may further enhance the demand for the market in the country due to a growing incidence of diabetes and the use of superior treatment methods.

Leading Players in the Diabetic Foot Ulcers Market

The key features of the market report include patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:

Smith & Nephew plc

Established in the year 1856 and headquartered in London, United Kingdom, the company specializes in the provision of advanced wound care dressings, negative pressure wound therapy devices, and skin substitutes. This is because the diabetic foot ulcer market is one of their core specialty areas as they concentrate on moist wound healing and infection prevention technologies to boost healing while at the same time minimizing complications.

ConvaTec Group

Founded in 1978 and based in the United Kingdom, they have a broad range of products like hydrocolloid dressings, foam dressings, and antimicrobial solutions that help provide the most suitable environment for diabetic foot ulcers. Their concern is fluid leakage and infection control, and both of these are important in patients with diabetes.

Molnlycke Health Care B.V.

Founded in 1849 and headquartered in Gothenburg, they deliver foam dressings along with antimicrobial dressings and advanced solutions for exudate management. Molnlycke underscores research and development, continuously innovating to elevate the management of chronic wounds, which includes diabetic foot ulcers.

Other companies include Solventum Corporation, Integra LifeSciences Holdings Corporation., Organogenesis Holdings Inc., MiMedx Group, Inc., Coloplast Group, and Essity Aktiebolag (publ).

Key Questions Answered in the Diabetic Foot Ulcers Market

• What was the diabetic foot ulcers market value in 2023?
• What is the diabetic foot ulcers market forecast outlook for 2024-2032?
• What are the regional markets covered in the EMR report?
• What is the market breakup based on the ulcer type?
• What is the market breakup based on the product?
• What is the market segmentation based on the end user?
• What major factors aid the diabetic foot ulcers market demand? 
• What are the market's major drivers, opportunities, and restraints? 
• Which regional market is expected to lead the market share in the forecast period? 
• Which country is expected to experience expedited growth during the forecast period? 
• What are the major diabetic foot ulcers market trends?
• How does the rise in the geriatric population impact the market size?
• Who are the key players in the diabetic foot ulcers market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
• What is the primary cause of neuropathic ulcers in diabetic patients?
• What are the key benefits of using wound care dressings in diabetic foot ulcers?
• Why are hospitals the leading segment in diabetic foot ulcer care?
• Why does the United States hold a significant share in the diabetic foot ulcer market?
• What factors are driving the growth of the diabetic foot ulcer market in India?